Co-Authors
This is a "connection" page, showing publications co-authored by YOCHAI BIRNBAUM and GLENN LEVINE.
Connection Strength
1.244
-
Do We Still Need Aspirin in Coronary Artery Disease? J Clin Med. 2023 Dec 06; 12(24).
Score: 0.244
-
Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines? Cardiovasc Drugs Ther. 2020 12; 34(6):865-870.
Score: 0.193
-
Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon. Cardiovasc Drugs Ther. 2019 10; 33(5):589-597.
Score: 0.182
-
Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions. Cardiovasc Drugs Ther. 2019 02; 33(1):105-117.
Score: 0.174
-
Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction? J Cardiovasc Pharmacol Ther. 2019 05; 24(3):215-224.
Score: 0.173
-
The CHA2DS2-VASc score: Not as simple as it seems. Int J Cardiol. 2018 04 15; 257:92-96.
Score: 0.165
-
Dual Antiplatelet Therapy: A Concise Review for Clinicians. Life (Basel). 2023 Jul 18; 13(7).
Score: 0.059
-
Meta-Analysis of Brief Dual-Antiplatelet Therapy Duration After Percutaneous Coronary Intervention. Am J Cardiol. 2022 07 01; 174:182-184.
Score: 0.055